Understanding Nicotine Use in People with Diabetes
Preventative Biomarkers and Potential Pharmacotherapies for Nicotine Use and Diabetes
This research explores why people with diabetes might be more likely to use nicotine and looks for new treatments to help them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-11126726 on NIH RePORTER |
What this research studies
This project uses animal models to understand the complex relationship between diabetes and nicotine use, especially focusing on how these issues affect women. Researchers want to discover if changes in the body related to diabetes, like insulin resistance, make nicotine more appealing or lead to stronger dependence. They will also test if certain medications can help reduce nicotine dependence in these models. The goal is to uncover the biological reasons behind this connection and find new ways to prevent and treat nicotine use in people living with diabetes.
Who could benefit from this research
Good fit: This foundational research is for individuals interested in the underlying causes of nicotine use in the context of diabetes.
Not a fit: Patients seeking immediate treatment options for nicotine dependence or diabetes will not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to new medications or strategies to help people with diabetes avoid or quit nicotine use.
How similar studies have performed: This work builds on prior pre-clinical findings that suggest a link between insulin signaling disruption and nicotine's rewarding effects.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Odell, Laura Elena — University of Texas El Paso
- Study coordinator: Odell, Laura Elena
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.